7-OH off the shelves: where to get help now

If you are reading this because 7-OH products are disappearing or you have decided you want to stop, this page is a practical list of where to go — including free options, options that do not require an in-person visit, and options for people who are not ready for treatment but want to stay safe.

You do not need to have all the answers before you make a call. You do not need to know what kind of help you want. The resources below are starting points, not commitments.

At a glance: your options

If you needStart here
Free 24/7 referrals, no commitmentSAMHSA National Helpline: 1-800-662-HELP (4357)
A treatment facility near youFindTreatment.gov (see the note below about a recent change)
Medication without leaving homeTelehealth buprenorphine providers — prescription via video visit, often same-day
Immediate emotional crisis support988 Suicide & Crisis Lifeline — call or text 988
Overdose protection while you figure things outNaloxone — available over the counter in most states

Key Takeaways

  • You have more options than you may think, and several are free. SAMHSA's helpline gives 24/7 referrals at no cost.
  • Telehealth is the fastest route to medication. Buprenorphine for opioid use disorder can currently be prescribed online without a prior in-person visit, often the same day.
  • FindTreatment.gov changed in June 2026. The ability to search for individual buprenorphine prescribers was removed. You can still search for facilities, or call the helpline.
  • If you are not ready for treatment, you can still stay safer. Get naloxone and do not use alone.
  • If you are in crisis, 988 is there. Losing access to something you have depended on, while facing the prospect of withdrawal, is genuinely hard. Calling is not an overreaction.

Start here: SAMHSA's free 24/7 helpline

SAMHSA National Helpline 1-800-662-HELP (4357) TTY: 1-800-487-4889 Text: Send your five-digit ZIP code to 435748 (HELP4U) for referrals by text

SAMHSA describes this as a free, confidential information and referral service, available 24 hours a day, 365 days a year, in English and Spanish. It connects callers to local treatment facilities, support groups, and community-based organizations.

What to expect: It is a referral line, not a treatment program. You can ask questions without giving your name or agreeing to anything. You are not starting treatment by calling — you are finding out what your options are.

What to say: You do not need the right vocabulary. "I've been using 7-OH tablets and I can't stop" is enough. If it helps, mentioning that it is an opioid product will get you routed to the right resources. If you are not sure whether 7-OH is an opioid, see Is 7-OH an Opioid? — the short answer is yes.

Text option: If calling feels like too much, the text line works the same way and does not require you to speak to anyone.

Finding treatment near you

FindTreatment.gov

SAMHSA's official treatment locator at FindTreatment.gov is searchable by location and service type, including facilities that offer medication for opioid use disorder. SAMHSA describes the search as confidential and anonymous.

⚠️ A change most pages have missed: As of June 1, 2026, SAMHSA decommissioned the underlying system that powered individual buprenorphine prescriber listings. The ability to search for individual prescribers by name has been removed from FindTreatment.gov. Facilities that provide buprenorphine treatment are still searchable.

If you are following older instructions to look up a specific prescriber on FindTreatment.gov and it is not working, that is why. Use the facility search, or call the SAMHSA helpline at 1-800-662-4357, which can still provide individual referrals.

Your existing primary care doctor

Since December 2022, any DEA-registered clinician with appropriate prescribing authority can prescribe buprenorphine for opioid use disorder without a separate addiction medicine waiver. Many people do not realize their regular doctor or nurse practitioner may already be authorized to prescribe it. Calling your primary care office and asking directly is a reasonable first step.

State-level resources

Many states have their own OUD treatment helplines, warm handoff programs, or medication access initiatives. SAMHSA's helpline can connect you to state-specific resources.

Getting medication without leaving home

Under federal rules currently in effect through December 31, 2026, buprenorphine for opioid use disorder can be prescribed via telehealth without a prior in-person medical evaluation. The prescriber must be DEA-registered and licensed in the state where you are located.

Why this matters if 7-OH is your situation: The most common barriers to seeking help are time, transportation, privacy, and not wanting to walk into a clinic. Telehealth removes all of those. A video visit, a prescription to your local pharmacy, and guidance on taking the first dose — from home, on your schedule.

Telehealth providers available in most states include Bicycle Health, which offers same-day evaluations and a care model that includes health coaching, support groups, and ongoing provider visits. For a full overview of how telehealth treatment works, see Can You Get Suboxone for 7-OH Addiction Online?

For the induction timing specific to 7-OH — which is different from other opioids because of the variable potency of commercial products — see How Long to Wait After 7-OH Before Suboxone.

Cost: Many insurance plans, including most private insurance, Medicare, and Medicaid, cover buprenorphine treatment for opioid use disorder. Cash-pay options and generic buprenorphine are available at most pharmacies. See current pricing and insurance options.

If you are not ready for treatment yet

This section is here because the goal is that you stay safe until you are ready, and that might not be today.

Get naloxone. Naloxone (Narcan) can reverse an opioid overdose, including from 7-OH. It is available over the counter at most pharmacies in most states without a prescription. During a supply disruption, when people may be obtaining products from unfamiliar sources with unpredictable potency, having naloxone on hand matters more than usual. Note: naloxone may require repeat doses for 7-OH (which has a longer half-life than some opioids), and any suspected overdose is a 911 situation even if naloxone is given.

Do not use alone. If you are still using 7-OH and the supply situation is creating uncertainty about what you are getting or how potent it is, having someone present who knows to call 911 and can administer naloxone if needed is a real harm-reduction measure.

Know the mixing risks. The situations where 7-OH use becomes fatal are almost always polysubstance. Alcohol and benzodiazepines with 7-OH produce dangerous synergistic respiratory depression. If you are using other substances alongside 7-OH, that is important information for any clinician you speak with. For the full picture, see Dangerous Kratom Drug Interactions.

The door stays open. Nothing on this page expires. The helpline number works whenever you are ready. The telehealth option works whenever you are ready. Whatever brings you back to this page later, the resources are still here.

If you are in crisis

988 Suicide & Crisis Lifeline Call or text 988 Available 24/7, in more than 150 languages

988 is not only for suicidal thoughts. It is for anyone in significant emotional distress. Losing access to something you have depended on daily, while facing the prospect of involuntary withdrawal, is a real crisis situation. Calling or texting 988 is not an overreaction.

If you are experiencing trouble breathing, unresponsiveness, or severe dehydration — call 911. Those are medical emergencies.

What to do this week

If you are trying to figure out what to do, here is a simple sequence:

Today: Make one call or send one text — the SAMHSA helpline at 1-800-662-4357 or a telehealth provider. Ask what treatment would look like for your specific situation. You are not committing to anything by asking.

This week: Get naloxone if you do not have it. It is at the pharmacy counter and usually costs between $20 and $40 without insurance, often less with GoodRx. Tell one person you trust what is going on.

Before supply runs out: Getting into treatment before products disappear means the transition is planned and clinically managed rather than forced and unmanaged. 7-OH withdrawal is opioid withdrawal — it starts within 6 to 12 hours of the last dose and peaks hard in the first few days. Having a clinical plan in place before that happens is substantially easier than managing it after.

For what withdrawal looks like: 7-OH Withdrawal Symptoms For the timeline of the ban: 7-OH Is Being Banned: What to Do If You Use It to Cope

Frequently Asked Questions

What is the fastest way to get help for 7-OH dependence?

The fastest route to medication is a telehealth evaluation. In most states, you can be evaluated by a licensed provider via video the same day you reach out and have a prescription sent to your local pharmacy. Call SAMHSA at 1-800-662-4357 for free referrals 24/7 if you want to explore options first.

Is the SAMHSA helpline confidential?

SAMHSA describes its National Helpline as a free and confidential service. This article does not make categorical promises about confidentiality or privacy in all circumstances. For questions about how specific information may or may not be shared in your situation, ask the helpline directly or consult a healthcare attorney.

Can I still find a buprenorphine prescriber on FindTreatment.gov?

Not by name. As of June 2026, individual prescriber listings were removed from FindTreatment.gov. You can still search for facilities that offer buprenorphine treatment. For help finding an individual prescriber, call the SAMHSA helpline or contact a telehealth provider directly.

What if I cannot afford treatment?

Medicaid covers buprenorphine treatment for opioid use disorder in most states. Medicare Part D covers the medication. Most private insurance plans cover it under mental health parity laws. Generic buprenorphine/naloxone is substantially less expensive than brand-name Suboxone and is available at most pharmacies. Discount programs like GoodRx can reduce cash-pay costs further. Call SAMHSA at 1-800-662-4357 to ask about free or low-cost options in your area.

What if I am not in the US?

This page covers US resources. If you are outside the United States, your country's health ministry or addiction medicine association is the appropriate starting point. The WHO's mental health and substance use resources at who.int/health-topics/mental-health may help identify local contacts.

Ready to start a planned transition?

Getting ahead of the supply disruption means the transition is yours to manage.

If you are experiencing a medical emergency, call 911. For crisis support, call or text 988. SAMHSA's free helpline: 1-800-662-4357, available 24/7. This article is for general informational purposes only and is not medical advice. Resource details are verified at the date above and subject to change.

Next Steps

Sources

  1. Substance Abuse and Mental Health Services Administration. SAMHSA National Helpline. https://www.samhsa.gov/find-help/national-helpline
  2. Substance Abuse and Mental Health Services Administration. FindTreatment.gov. https://findtreatment.gov
  3. Drug Enforcement Administration. Schedules of Controlled Substance: Temporary Placement of 7-Hydroxymitragynine Above a Specified Threshold in Schedule I. Federal Register. Published July 6, 2026. https://www.federalregister.gov/documents/2026/07/06/2026-13580/schedules-of-controlled-substance-temporary-placement-of-7-hydroxymitragynine-above-a-specified
  4. Substance Abuse and Mental Health Services Administration. Changes to SAMHSA Treatment Locator: Individual Practitioner Listings Removed. SAMHSA Notice. June 2026. https://findtreatment.gov
  5. 988 Suicide & Crisis Lifeline. About 988. https://988lifeline.org/about/
  6. U.S. Food and Drug Administration. 7-Hydroxymitragynine (7-OH): An Assessment of the Scientific Data and Toxicological Concerns Around an Emerging Opioid Threat. FDA; July 2025. https://www.fda.gov/files/drugs/published/7-hydroxymitragynin_7-oh_an_assessment_of_the_scientific_data_and_toxicological_concerns_around_an_emerging_opioid_threat.pdf
  7. Drug Enforcement Administration and U.S. Department of Health and Human Services. Expansion of Buprenorphine Treatment via Telemedicine Encounter. Federal Register. 90 FR 6504. Published January 17, 2025; effective December 31, 2025. https://www.federalregister.gov/documents/2025/01/17/2025-01049/expansion-of-buprenorphine-treatment-via-telemedicine-encounter
  8. Barrett E, Hendy L, Lira MC, et al. What Clinicians Should Know About Kratom and 7-OH Mitragynine. AIM Clinical Cases (Annals of Internal Medicine: Clinical Cases). 2026;5:e251249. doi:10.7326/aimcc.2025.1249.
This article is for educational purposes only and is not a substitute for professional medical advice. If you are experiencing severe withdrawal symptoms, contact a healthcare provider or go to your nearest emergency room.